Other languages Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Market Closed - Nasdaq Other stock markets 04:30:01 2024-06-04 pm EDT			5-day change	1st Jan Change
1.615 ^USD	-0.92%		-0.31%	-7.18%

May. 28	Sonnet Biotherapeutics Holdings, Inc. to Present SB221 as A Trial in Progress At the Asco 2024 Annual Meeting	CI
May. 22	Sonnet BioTherapeutics Holdings, Inc. Announces Review of Strategic Alternatives	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sonnet Biotherapeutics Holdings, Inc. to Present SB221 as A Trial in Progress At the Asco 2024 Annual Meeting	May. 28
Sonnet BioTherapeutics Holdings, Inc. Announces Review of Strategic Alternatives	May. 21
Sonnet BioTherapeutics Holdings, Inc. Announces Updated Clinical Data for Son-1010 as Monotherapy or Combined with an Anti-Pd-L1, Along with an Increase in the Dose-Escalation Target	May. 20
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 14
Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street	Mar. 11
Top Premarket Gainers	Mar. 11
Sonnet BioTherapeutics Holdings, Inc. Announces First Phase 1b/2a Clinical Trial of SON-080	Mar. 11
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 14
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 14
Sector Update: Health Care Stocks Retreating Late Afternoon	23-10-25
Top Midday Decliners	23-10-25
Top Premarket Decliners	23-10-25
Sector Update: Health Care Stocks Lower in Late Afternoon Trading	23-08-31
Sector Update: Health Care Stocks Lower Thursday Afternoon	23-08-31
Sonnet BioTherapeutics to Implement 1-for-22 Reverse Stock Split; Shares Fall	23-08-31
Sector Update: Health Care Stocks Decreasing Late Afternoon	23-08-16
Sector Update: Health Care Stocks Lower Wednesday Afternoon	23-08-16
Sector Update: Health Care	23-08-16
Top Midday Gainers	23-08-16
Sonnet BioTherapeutics Says FDA Accepts IND for Trial of Ovarian Cancer Treatment; Shares Jump	23-08-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Other languages

Filters